Pharmaceutical Research

, Volume 4, Issue 6, pp 445–449 | Cite as

The Influence of Drugs on Nasal Ciliary Movement

  • Walter A. J. J. Hermens
  • Frans W. H. M. Merkus
Article

Abstract

Drugs in nasal preparations, for local use as well as for systemic use, should not interfere with the self-cleaning capacity of the nose, effectuated by the ciliary epithelium. Many drugs and additives, however, have a negative effect on nasal ciliary function. Examples of ciliotoxic agents are lipophilic and mercuric preservatives, local anesthetics, antihistamines, propranolol, and absorption enhancers such as the bile salts. Cholinergic drugs and β-adrenergic drugs exert a ciliostimulatory effect. It is the purpose of this review to summarize the present knowledge of ciliotoxicity of drugs and additives and to give recommendations for the use of ciliofriendly drugs in nasal preparations.

ciliary movement ciliotoxicity nasal drug delivery 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Y. W. Chien. Transnasal Systemic Medications. Fundamentals, Developmental Concepts and Biomedical Assessments, Elsevier, Amsterdam, 1985.Google Scholar
  2. 2.
    A. W. Proetz. Trans. Am. Laryngol. Assoc. 54:264–273 (1932).Google Scholar
  3. 3.
    B. A. Afzelius. Int. Rev. Exp. Pathol. 19:10–43 (1979).Google Scholar
  4. 4.
    G. S. M. J. E. Duchateau, K. Graamans, J. Zuidema, and F. W. H. M. Merkus. Laryngoscope 95:854–859 (1985).Google Scholar
  5. 5.
    G. Ewert. Acta Otolaryngol. 200 (Suppl.):1–62 (1965).Google Scholar
  6. 6.
    I. Anderson, P. Camner, P. L. Jensen, K. Philipson, and D. F. Procter. Am. Rev. Resp. Dis. 110:301–305 (1974).Google Scholar
  7. 7.
    H. J. M. van de Donk, A. G. M. van den Heuvel, J. Zuidema, and F. W. H. M. Merkus. Rhinology 20:127–137 (1982).Google Scholar
  8. 8.
    D. Passali, L. Bellussi, M. Bianchini Ciampoli, and E. De Seta. Acta Otolaryngol. 97:319–323 (1984).Google Scholar
  9. 9.
    T. Dalhamn. Acta Physiol. Scand. 33:1–5 (1955).Google Scholar
  10. 10.
    I. Anderson. Thesis, University of Århus, Århus, Denmark, 1971.Google Scholar
  11. 11.
    W. I. Lee and P. Verdugo. Biophys. J. 16:1115–1119 (1976).Google Scholar
  12. 12.
    T. Dalhamn and R. Rylander. Nature 196:592–593 (1962).Google Scholar
  13. 13.
    U. Mercke, C. H. Hakansson, and N. G. Toremalm. Acta Otolaryngol. 78:118–123 (1974).Google Scholar
  14. 14.
    J. Yager, Tzeng-Ming Chen, and M. J. Dulfano. Chest 73:627–633 (1978).Google Scholar
  15. 15.
    H. J. M. van de Donk, J. Zuidema, and F. W. H. M. Merkus. Rhinology 18:93–104 (1980).Google Scholar
  16. 16.
    N. Konietzko, J. A. Nakhosteen, W. Mizera, R. Kasparek, and H. Hesse. Chest 80:855–858 (1981).Google Scholar
  17. 17.
    J. R. Kennedy and K. E. Duckett. Exp. Cell. Res. 135:147–156 (1981).Google Scholar
  18. 18.
    M. T. Lopez-Vidriero. Am. Rev. Resp. Dis. 125 (Suppl. 4):244 (1982).Google Scholar
  19. 19.
    J. Rutland, W. H. Griffin, and P. J. Cole. Am. Rev. Resp. Dis. 125:100–105 (1982).Google Scholar
  20. 20.
    K. Ukai, Y. Sakakura, and S. Saide. Arch. Otorhinolaryngol. 242:225–231 (1985).Google Scholar
  21. 21.
    P. C. Braga, G. Dall'Oglio, R. Bossi, and L. Allegra. J. Pharm. Meth. 16:161–169 (1986).Google Scholar
  22. 22.
    H. Teichtahl, P. L. Wright, and R. L. G Kirsner. Med. Biol. Eng. Comp. 24:193–196 (1986).Google Scholar
  23. 23.
    C. Galley. Pharm. Acta Helv. 35:358–374 (1960).Google Scholar
  24. 24.
    J. D. Cherry and D. Taylor-Robinson. Infect. Immun. 2, (4)431–438 (1970).Google Scholar
  25. 25.
    H. J. M. van de Donk, I. P. Muller-Plantema, J. Zuidema, and F. W. H. M. Merkus. Rhinology 18:119–133 (1980).Google Scholar
  26. 26.
    J. P. Dudley and J. D. Cherry. Laryngoscope 88:110–116. (1978).Google Scholar
  27. 27.
    H. J. M. van de Donk, J. Zuidema, and F. W. H. M. Merkus. Rhinology 19:215–230 (1981).Google Scholar
  28. 28.
    H. J. M. van de Donk, S. Jadoenath, J. Zuidema, and F. W. H. M. Merkus. Int. J. Pharm. 12:57–65 (1982).Google Scholar
  29. 29.
    L. Hill. Lancet 215:802–805 (1928).Google Scholar
  30. 30.
    K. S. Lee and S. S. Park. Anesth. Analg. 59:426–430 (1980).Google Scholar
  31. 31.
    H. J. M. van de Donk, A. L. M. van Egmond, A. G. M. van den Heuvel, J. Zuidema, and F. W. H. M. Merkus. Int. J. Pharm. 12:77–85 (1982).Google Scholar
  32. 32.
    B. R. Manawadu, S. R. Mastow, and F. M. La Force. Anesth. Analg. 57:448–452 (1978).Google Scholar
  33. 33.
    H. J. M. Van de Donk, A. L. M. van Egmond, J. Zuidema, and F. W. H. M. Merkus. Int. J. Pharm. 12:67–76 (1982).Google Scholar
  34. 34.
    N. G. Toremalm, K. Josefsson, K. Klementsson, and I. Lagergren. Acta Pharmacol. Toxicol. 51:103–107 (1982).Google Scholar
  35. 35.
    N. G. Toremalm, K. Josefsson, and I. Lagegren. Pharmacology 26:40–45 (1983).Google Scholar
  36. 36.
    G. S. M. J. E. Duchateau, J. Zuidema, and F. W. H. M. Merkus. Allergy 41:260–265 (1986).Google Scholar
  37. 37.
    A. M. J. N. Blair and A. Woods. Br. J. Pharmacol. 35:379P-380P (1969).Google Scholar
  38. 38.
    G. N. Melville, S. Ismail, and C. Sealy. Respiration 40:329–336 (1980).Google Scholar
  39. 39.
    S. Yanaura, N. Imamura, and M. Misawa. Jpn. J. Pharmacol. 31:957–965 (1981).Google Scholar
  40. 40.
    P. P. Low, M. J. Dulfano, C. K. Luk, and P. J. P. Finch. Ann. Allergy 54:273–275 (1985).Google Scholar
  41. 41.
    G. Stafanger, H. Bisgaard, M. Pedersen, E. Morkassel, and C. Kock. Eur. J. Resp. Dis. 70:157–162 (1987).Google Scholar
  42. 42.
    R. B. Dreisin and S. R. Mostov. J. Lab. Clin. Med. 93:674–678 (1979).Google Scholar
  43. 43.
    S. Yanaura, N. Imamura, and M. Misawa. Jpn. J. Pharmacol. 31:951–956 (1981).Google Scholar
  44. 44.
    J. Irvani and G. N. Melville. Respiration 32:157–164 (1975).Google Scholar
  45. 45.
    Y. Ohashi, Y. Nakai, K. Zushi, M. Maraoka, Y. Minowa, H. Harada, and H. Masutani. Acta Otolaryngol. (Suppl.) 397:49–59 (1983).Google Scholar
  46. 46.
    N. Konietzko, R. Kasparek, U. Kellner, and J. Petro. Prax. Klin. Pneumol. 37:904–906 (1983).Google Scholar
  47. 47.
    J. C. Hybbinette and U. Mercke. Acta Otolaryngol. 94:121–130 (1982).Google Scholar
  48. 48.
    W. H. Foster, E. H. Bergofsky, D. E. Bohning, M. Lippmann, and R. E. Alberts. J. Appl. Physiol. 41:146–152 (1976).Google Scholar
  49. 49.
    M. T. Lopez-Vidriero, M. Jacobs, and S. W. Clarke. Eur. J. Pharmacol. 112:429–432 (1985).Google Scholar
  50. 50.
    J. C. Hybbinette and U. Mercke. Acta Otolaryngol. 93:465–473 (1982).Google Scholar
  51. 51.
    D. J. Nelson and E. M. Wright. J. Physiol. 243:855–857 (1974).Google Scholar
  52. 52.
    A. Wanner. Am. J. Med. 79:16–21 (1985).Google Scholar
  53. 53.
    A. Hussain, T. Foster, S. Hirai, T. Kashihara, R. Batenhorst, and M. Jones. J. Pharm. Sci. 69:1240 (1980).Google Scholar
  54. 54.
    H. J. M. van de Donk and F. W. H. M. Merkus. J. Pharm. Sci 71:595–596 (1982).Google Scholar
  55. 55.
    G. S. M. J. E. Duchateau, J. Zuidema, W. A. J. J. Hermens, and F. W. H. M. Merkus. Int. J. Pharm. 31:275–276 (1986).Google Scholar
  56. 56.
    A. Hussain, R. Kimura, C. H. Huang, and T. Kashihara. Int. J. Pharm. 21:233–237 (1984).Google Scholar
  57. 57.
    W. A. J. J. Hermens, M. T. I. W. Schüsler-van Hees, and F. W. H. M. Merkus. Acta Pharm. Techn. 33:88–90 (1987).Google Scholar
  58. 58.
    G. S. M. J. E. Duchateau, J. Zuidema, and F. W. H. M. Merkus. Int. J. Pharm. 31:193–199 (1986).Google Scholar
  59. 59.
    G. S. Gordon, A. C. Moses, R. D. Silver, J. S. Flier, and M. C. Carey. Proc. Natl. Acad. Sci. 82:7419–7423 (1985).Google Scholar
  60. 60.
    W. A. J. J. Hermens, M. T. I. W. Schüsler-van Hees, and F. W. H. M. Merkus. Pharm. Weekbl. (Sci.) 9 (1987) (in press).Google Scholar

Copyright information

© Plenum Publishing Corporation 1987

Authors and Affiliations

  • Walter A. J. J. Hermens
    • 1
  • Frans W. H. M. Merkus
  1. 1.Center for Bio-Pharmaceutical SciencesLeiden UniversityRA LeidenThe Netherlands

Personalised recommendations